| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020049 |
| Receipt No. | R000023155 |
| Official scientific title of the study | Randomized double-blind study for the effect of theaflavin on oral bacterial flora |
| Date of disclosure of the study information | 2015/12/03 |
| Last modified on | 2019/03/01 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Randomized double-blind study for the effect of theaflavin on oral bacterial flora | |
| Title of the study (Brief title) | Randomized double-blind study for the effect of theaflavin on oral bacterial flora | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteers | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To determine the effect of teaflavin on oral bacterial flora |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Periodontopathic-bacteria after taking teaflavin tablets for 3 or 6 weeks
(1.P.gingivalis 2.F.nucleatum) |
| Key secondary outcomes | Following indicators after taking teaflavin tablets for 3 or 6 weeks
1) Gingival index:GI 2) Plaque index: PI 3) Bleeding on Probing: BOP 4) Cariogenic bacteria |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Theaflavin tablet,
8 mg/2tablets/day, 6 weeks |
|
| Interventions/Control_2 | Placebo tablet,
0 mg/2 tablets/day, 6 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Subjects who are not appropriate to examine oral bacterial flora
2. Subjects who are not under treatment for dental caries and/or periodontal disease and have enough tooth (20 tooth<=) |
|||
| Key exclusion criteria | 1. Subjects who are under treatment with mouse rinse
2. Subjects with diabetes, CKD, gastrointestinal diseases, lung diseases and/or cancer. 3. Subjects who are not appropriate to amount and pH of saliva. 4. Subjects with dental caries and/or periodontal disease 5. Subjects using removable denture 6. Antibiotics 7. drug and/or alcohol dependence 8. Pregnancy and nursing 9. Subjects who participate in other clinical trials at the time of this study entry |
|||
| Target sample size | 56 | |||
| Research contact person | |
| Name of lead principal investigator | Tatsuya Morimoto |
| Organization | Pharmaceutical Science, University of Shizuoka |
| Division name | Division of Molecular Medicine |
| Address | 52-1 Yada, Suruga-ku, Shizuoka |
| TEL | 0542645763 |
| morimoto@u-shizuoka-ken.ac.jp | |
| Public contact | |
| Name of contact person | Eiji Yoshikawa |
| Organization | KSO Corporation |
| Division name | Sales department |
| Address | 1-9-7 Shibaura, Minato-ku, Tokyo |
| TEL | 03-3452-7733 |
| Homepage URL | |
| yoshikawa@kso.co.jp | |
| Sponsor | |
| Institute | University of Shizuoka |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shizuoka industrial foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023155 |